$吉利德科学(GIL_老虎社区_美港股上老虎

狂龙
2020-05-24

$吉利德科学(GILD)$新型抗炎药！吉利德JAK1抑制剂filgotinib治疗中重度活动性溃疡性结肠炎(UC)III期临床获得成功！

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":953605299,"tweetId":"953605299","gmtCreate":1590283512911,"gmtModify":1704192282994,"author":{"id":3464147665993463,"authorId":3464147665993463,"authorIdStr":"3464147665993463","name":"狂龙","avatar":"https://static.tigerbbs.com/88bd3e4e5a4ae9b4758e5f72062cc4b9","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":33,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$</a>新型抗炎药！吉利德JAK1抑制剂filgotinib治疗中重度活动性溃疡性结肠炎(UC)III期临床获得成功！</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$</a>新型抗炎药！吉利德JAK1抑制剂filgotinib治疗中重度活动性溃疡性结肠炎(UC)III期临床获得成功！</p></body></html>","text":"$吉利德科学(GILD)$新型抗炎药！吉利德JAK1抑制剂filgotinib治疗中重度活动性溃疡性结肠炎(UC)III期临床获得成功！","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/953605299","repostId":0,"isVote":1,"tweetType":1,"viewCount":2166,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["GILD"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":105,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}